Swiss pharma lags behind in global innovation ranking
An employee works on the production of the Pfizer-BioNTech COVID-19 vaccine at a factory in Marburg, Germany, on January 20, 2021.
Keystone / Biontech Se Handout
Pharmaceutical companies are currently among the most innovative firms in the world alongside tech and software giants such as Apple and Alphabet, according to the Boston Consulting Group (BCG). But Swiss pharma companies rank low in their latest Top 50 list.
This content was published on
2 minutes
Keystone-SDA/swissinfo/sb
Español
es
La farmacéutica suiza se rezaga en ranking de innovación
“Pharma companies performed strongly this year, joining technology and software companies that have dominated the rankings in recent years,” said BCG in a statementExternal link on Thursday. The group have released their “Most Innovative Companies 2021” report that features a Top 50 ranking.
In 2021, nine pharmaceutical companies were ranked by BCG experts among the 50 most innovative companies, three times more than the previous year.
US pharmaceutical companies Pfizer and Johnson & Johnson, which have developed vaccines against Covid-19, were ranked the 10th and 20th most innovative firms. Abbott Labs (29th) and Merck & Co (35th) also featured highly in the table that was topped by Apple, Alphabet, Amazon, Microsoft and Tesla.
Swiss pharmaceutical giants Novartis and Roche, which did not launch any Covid vaccines, were ranked 36th and 48th most innovative firms, respectively. They were nonetheless ahead of the British-Swedish multinational AstraZeneca (49th) and the German firm Bayer (50th).
More
More
The Swiss Connection Podcast: Hear Swiss science stories for the world
Why is Switzerland so sweet on cryptocurrency? What’s it like to be a Swiss expat in America? Swiss women couldn’t vote until when?!
While not at the forefront in developing vaccines, Swiss companies have been stepping up their involvement in manufacturing Covid-19 vaccines. Lonza is producing ingredients for the Moderna vaccine at its production plant in Visp, southern Switzerland, while pharma giant Novartis has signed deals to help manufacture both the Pfizer/BioNtech and CureVac vaccines. Roche has been focusing on Covid-19 tests and treatments.
The question of whether Switzerland should have developed its own Covid vaccines has been in the headlines in recent weeks. Swiss Health Minister Alain Berset has been caught up in a controversy for reportedly turning down an offer by Lonza to produce vaccines domestically.
Newspapers have claimed that in spring 2020 Berset missed the chance to secure a Swiss-based vaccine production line via Lonza. Berset has since said there was no clear connection between investing in Lonza and securing access to the Moderna vaccine.
A parliamentary commission plans to investigate the matter. It’s not known when their findings will be published.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
Switzerland targets 65% cut in greenhouse gas emissions by 2035
This content was published on
Switzerland has set an ambitious goal to cut its greenhouse gas emissions by at least 65% by 2035, compared to 1990 levels.
Switzerland cuts foreign aid to Albania, Bangladesh and Zambia
This content was published on
This decision comes after the parliament allocated less funding for foreign aid in December than the government had requested.
Switzerland to end international adoptions by 2026
This content was published on
Swiss citizens will no longer be able to adopt children from abroad. The government plans to halt these adoptions to prevent potential abuses.
Home ownership costs in Switzerland up by 2% in 2024
This content was published on
Home ownership in Switzerland became slightly more expensive in 2024. Central Switzerland has the priciest single-family homes at CHF1.78 million.
This content was published on
Six months into his tenure, Vice Chancellor Andrea Arcidiacono said he will leave the Federal Chancellery at the end of March.
Swiss Muslim campaigner faces defamation complaint
This content was published on
The Vaudois Union of Muslim Associations continues its defamation complaint against Saïda Keller-Messahli for her remarks in Le Matin Dimanche.
DRC fighting: UN reports rape and relocates non-essential staff
This content was published on
The UN has moved non-essential staff from Goma in the DRC, after M23 rebels entered on Monday. Reports of rape and looting have emerged.
Switzerland in race for sufficient Covid immunisation
This content was published on
Health authorities have called for an extra effort from the Swiss population to keep Covid infections as low as possible in the next few months.
Switzerland mulls future European coordination on medical supplies
This content was published on
“The pandemic has shown us that we are very dependent, maybe too much so, on other markets,” Swiss President Guy Parmelin has said.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.